Vivactis Market Access attended the Science for Health event on November 21st
The Science for Health event was organised by MedVIA and took place at SQUARE Brussel in Belgium. This years topic: Advancing Gene Therapy
Gene therapy could enable patients to live without the need for ongoing treatments or the burden of daily disease management. How are we turning this promise into reality?
We joined to get the latest insights from local and international experts discussing the current and future treatment modalities, how to address technical or regulatory challenges and build clinical evidence.
Interesting round table about “The value of gene therapy and how to secure access for patients”, Steven Simoens (KU Leuven), Eva Schoeters (RaDiOrg), Dirk Vandermijnsbrugge (Pfizer), Ingrid Maes (Innovigate), Bart Leroy (UZ Gent), and moderated by Ann Van Gysel (MEDVIA)
About Science for Health
At this yearly event, experts are connected around a central theme to promote out-of-the-box thinking and spark new research collaborations. This strengthens the local ecosystem and creates inspired solutions improving the life of patients.
About MEDVIA
MEDVIA is the newest of seven spearhead clusters in Flanders, Belgium. More than 90 members have joined us to support and develop innovative technologies that offer better services to patients. Our members are dedicated to projects at the crossroads of biotech, medtech and digital technologies.
